24 results
8-K/A
EX-99.1
COGT
Cogent Biosciences Inc
16 Jun 22
Entry into a Material Definitive Agreement
5:03pm
to fund our operations in future periods; our use of the net proceeds of the underwritten public offering; the impact of the COVID-19 pandemic
8-K
EX-10.1
gpi7eb 6ig8owrp
9 Jul 21
Entry into a Material Definitive Agreement
4:01pm
DEFM14A
jytll88e1ga1
9 Oct 20
Proxy related to merger
4:44pm